Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • MUC16 gene up-regulates gene transcripts associated with cisplatin resistance in human ovarian cancer cells
    Meeting Abstract

    Thapi, D.; Rosales, N.; Ma, X.; Kehoe, S. M.; Diaz, J. P.; Spriggs, D. R.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
    Meeting Abstract

    Jaggi, J. S.; Henke, E.; Seshan, S.; Kappel, B.; Chattopadhyay, D.; May, C.; McDevitt, M. R.; Benezra, R.; Scheinberg, D. A.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • An MMR control RNA for reliable monitoring of BCR-ABL transcripts in treated CML patients
    Meeting Abstract

    Toplin, J.; Fuller, C.; Fletcher, L.; Wong, S.; Maslak, P.; Cortes, J.; Mazanet, R.; Branford, S.; Hughes, T.; Galderisi, C.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Enhanced anti-tumor efficacy of genetically modified T cells through the up-regulated expression of CD154 (CD40L)
    Meeting Abstract

    Seinstra, B.; Nikhamin, Y.; Brentjens, R.
    Human Gene Therapy (2007)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Pilot study of a Wilms tumor protein (WT1) heteroclitic peptide vaccine in patients with myeloid and thoracic neoplasms
    Meeting Abstract

    Maslak, P. G.; Krug, L.; Chanel, S.; Dao, T.; James, L.; Tyson, L.; Bekele, S.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Efficacy and long term survival of genetically modified T cells targeting CD19 in a syngeneic immune competent transgenic murine tumor model is dependent on prior lymphodepleting chemotherapy
    Meeting Abstract

    Lee, J.; Nikhamin, Y.; Imperato, G.; Cohen, A.; Sadelain, M.; Brentjens, R.
    Blood (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, rituximab, and mitoxantrone (PCRM): A new highly active regimen for patients with chronic lymphocytic leukemia (CLL) previously treated with PCR or FCR
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Brentjens, R. J.; Jurcic, J. G.; Weiss, M. A.
    Blood (2007)

    Fulltext@MSK | Save